We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+2.77%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$3.23B
AUM Growth
-$162M
(-4.8%)
Cap. Flow
-$213M
Cap. Flow
% of AUM
-6.6%
Top 10 Holdings %
Top 10 Hldgs %
19.05%
Holding
1,571
New
110
Increased
706
Reduced
485
Closed
203
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$38.9M |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$34M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$14.7M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$13.2M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$101M |
| 2 |
BCS.PRD.CL
Barclays Bank Plc
BCS.PRD.CL
|
+$45.7M |
| 3 |
Fidelity MSCI Consumer Staples Index ETF
FSTA
|
+$34.6M |
| 4 |
PIMCO Active Bond Exchange-Traded Fund
BOND
|
+$33M |
| 5 |
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
|
+$17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.3% |
| 2 | Technology | 5.26% |
| 3 | Energy | 5.22% |
| 4 | Healthcare | 4.79% |
| 5 | Industrials | 4.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPL
401
DELISTED
Buckeye Partners, L.P.
BPL
| $1.34M | 0.04% |
17,723
+829
| +5% | +$63.9K |
|
|
CB
402
DELISTED
CHUBB CORPORATION
CB
| $1.34M | 0.04% |
12,931
+296
| +2% | +$29.5K |
|
403
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.42B
| $1.33M | 0.04% |
30,541
+14,191
| +87% | +$606K |
|
|
MMP
404
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $1.32M | 0.04% |
16,004
-2,197
| -12% | -$180K |
|
405
Eaton Vance Tax-Managed Diversified Equity Income Fund
ETY
$2.33B
| $1.32M | 0.04% |
118,387
+3,210
| +3% | +$36.7K |
|
406
Fortune Brands Innovations
FBIN
$5.98B
| $1.31M | 0.04% |
33,869
+201
| +0.6% | +$7.36K |
|
407
KLA
KLAC
$263B
| $1.3M | 0.04% |
185,070
+3,200
| +2% | +$23.6K |
|
408
MetLife
MET
$61.7B
| $1.3M | 0.04% |
26,990
+796
| +3% | +$37.8K |
|
409
Ameren
AEE
$29.6B
| $1.3M | 0.04% |
28,144
+162
| +0.6% | +$6.89K |
|
410
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.89B
| $1.29M | 0.04% |
64,090
+6,400
| +11% | +$124K |
|
411
American Tower
AMT
$79.2B
| $1.28M | 0.04% |
12,955
+2,061
| +19% | +$202K |
|
412
Sherwin-Williams
SHW
$88.9B
| $1.28M | 0.04% |
14,595
+642
| +5% | +$50.6K |
|
|
AET
413
DELISTED
Aetna Inc
AET
| $1.27M | 0.04% |
14,334
+1,884
| +15% | +$158K |
|
414
Constellation Brands
STZ
$22.6B
| $1.27M | 0.04% |
12,926
+605
| +5% | +$55.4K |
|
415
UGI
UGI
$7.28B
| $1.27M | 0.04% |
33,364
+18,949
| +131% | +$699K |
|
416
Becton Dickinson
BDX
$49.2B
| $1.26M | 0.04% |
9,304
+999
| +12% | +$128K |
|
417
Ventas
VTR
$45.5B
| $1.26M | 0.04% |
15,371
+1,865
| +14% | +$147K |
|
418
Teva Pharmaceuticals
TEVA
$43B
| $1.25M | 0.04% |
21,767
-883
| -4% | -$49.2K |
|
|
RGP
419
DELISTED
REGENCY ENERGY PARTNERS LP COMMON UTS REP LIMITED PART INTS
RGP
| $1.25M | 0.04% |
52,170
+154
| +0.3% | +$4.36K |
|
420
BGC Group
BGC
$4.88B
| $1.25M | 0.04% |
212,441
-5,093
| -2% | -$27.3K |
|
421
Hercules Capital
HTGC
$3.14B
| $1.25M | 0.04% |
83,647
+167
| +0.2% | +$2.52K |
|
422
VanEck Preferred Securities ex Financials ETF
PFXF
$2.45B
| $1.24M | 0.04% |
60,222
+16,439
| +38% | +$338K |
|
423
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.56B
| $1.23M | 0.04% |
21,681
-16,405
| -43% | -$961K |
|
|
ASBI
424
DELISTED
AMERIANA BANCORP
ASBI
| $1.23M | 0.04% |
71,800
-650
| -0.9% | -$10.7K |
|
425
Factset
FDS
$10.1B
| $1.23M | 0.04% |
8,703
+4,397
| +102% | +$584K |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q4 2014 Portfolio in Review
As of Q4 2014, Cambridge Investment Research Advisors held 1,571 positions worth $3.23B, down 4.8% from $3.39B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Cambridge Investment Research Advisors withdrew a net $213M in Q4 2014, closing 203 positions and reducing 485 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $101M position sold in full.
By sector, the portfolio is most concentrated in Financials at 5.3% of assets, up from 4.9% a quarter earlier, followed by Technology and Energy.
Against the trend, Cambridge Investment Research Advisors opened a new position in Vanguard Long-Term Treasury ETF worth $1.5M.
- Cambridge Investment Research Advisors's largest Q4 2014 buy was Vanguard Long-Term Treasury ETF: 19,313 shares worth $1.5M.
- Cambridge Investment Research Advisors added most to Vanguard Total Bond Market in Q4 2014, an estimated $38.9M increase.
- Cambridge Investment Research Advisors's biggest Q4 2014 reduction was Barclays Bank Plc, cutting an estimated $45.7M.
- Cambridge Investment Research Advisors fully exited Vanguard S&P 500 ETF in Q4 2014, selling an estimated $101M.
- Cambridge Investment Research Advisors's ten largest holdings make up 19% of its $3.23B portfolio in Q4 2014.
- Cambridge Investment Research Advisors opened 110 new positions and closed 203 in Q4 2014.
- Cambridge Investment Research Advisors's portfolio value fell 4.8% quarter-over-quarter to $3.23B.
Based on Cambridge Investment Research Advisors's 13F filing for Q4 2014, filed 6 Feb 2015.